保乳術聯合前哨淋巴結活檢治療乳腺癌30例臨床療效分析

潘洪濤 閆小軍

[摘要] 目的 乳腺癌是惡性腫瘤疾病的一種，應通過有效的手段完成治療，達到促進患者康復的目的。方法 納入到該院進行乳腺癌治療的患者進行對比，方便選取其中的例數為30例，研究對象的收集時間為2018年5月—2019年5月，根據患者選擇的不同治療方法完成分組，設置一組為對照組，采用傳統乳腺癌根治術治療，另一組為實驗組，采用保乳術聯合前哨淋巴結活檢治療，對比患者治療結果。結果 經過對比，實驗組患者的圍術期各項指標效果顯著[（61.08±9.63）min、（61.62±10.78）mL、（1.23±0.84）d]，差異有統計學意義（t=8.624，17.246，4.302，P<0.05）;與對照組相比，實驗組患者的生活質量更高（92.62±9.62）分，差異有統計學意義（t=2.594，P=0.015）;將實驗組患者的并發癥發生率（0.00%）與對照組相比顯著較低（26.64%），差異有統計學意義（χ2=4.615，P=0.032）。結論 保乳術聯合前哨淋巴結活檢治療乳腺癌臨床效果較為顯著，值得推廣。

[關鍵詞] 保乳術;前哨淋巴結活檢;乳腺癌;傳統乳腺癌根治術;療效

[Abstract] Objective Breast cancer is a kind of malignant tumor disease. Treatment should be completed by effective means to promote the recovery of patients. Methods The patients enrolled in our hospital for breast cancer treatment were compared， and 30 cases were convenient selected. The collection time of the study subjects was 2018.05-2019.05. Grouping was completed according to the different treatment methods selected by the patients， and a group was set as the control group. The patients were treated with traditional radical mastectomy， and the other group was the experimental group. The breast-conserving surgery combined with sentinel lymph node biopsy was used to compare the treatment results of the patients. Results After comparison， the perioperative indicators of the experimental group were significant [（61.08±9.63） min， （61.62±10.78）mL， （1.23±0.84）d]， and the differences were statistically significant （t=8.624，17.246， 4.302， P<0.05）; compared with the control group， the quality of life of patients in the experimental group was higher（92.62±9.62） points， which was statistically significant （t=2.5941， P=0.015）; The incidence of disease （0.00%） was significantly lower than that of the control group（26.64%）， which was statistically significant （χ2=4.615， P=0.032）. Conclusion Breast-conserving surgery combined with sentinel lymph node biopsy has a significant clinical effect on breast cancer， and is worthy of promotion.

[Key words] Breast-conserving surgery; Sentinel lymph node biopsy; Breast cancer; Traditional radical mastectomy; Efficacy

乳腺癌在我國臨床中發病率相對較高，占全身各種惡性腫瘤疾病發病率的7%～10%之間，是威脅女性生殖健康的重要疾病。近年來，乳腺癌的發病率逐漸呈上升趨勢發展，臨床中常采用外科手術進行治療，傳統的乳腺癌根治術具有較大的創傷，并且手術時間較長，由此可引發多種并發癥的發生，不利于術后提高患者的生活質量，當下臨床中治療乳腺癌不僅在于將疾病徹底根治，同時需要提高患者的術后生活質量[1]。前哨淋巴結是乳腺癌向腋窩淋巴結引流過程中的重要途徑，能夠在手術過程中避免腋窩血管、淋巴管神經受到傷害，同時能夠降低上肢水腫等多種并發癥的發生，保乳聯合前哨淋巴結活檢術在治療乳腺癌過程中，可進一步提高患者的生活質量[2]。該文從2018年5月—2019年5月的30例乳腺癌患者入手，探究保乳術聯合前哨淋巴結活檢治療療效，現報道如下。

1? 資料與方法

1.1? 一般資料